Cell-cell interactions mediating primary and metastatic breast cancer dormancy
- PMID: 39585533
- DOI: 10.1007/s10555-024-10223-5
Cell-cell interactions mediating primary and metastatic breast cancer dormancy
Abstract
Breast cancer remains one of the leading causes of death in women around the world. A majority of deaths from breast cancer occur due to cancer cells colonizing distant organ sites. When colonizing these distant organ sites, breast cancer cells have been known to enter into a state of dormancy for extended periods of time. However, the mechanisms that promote dormancy as well as dormant-to-proliferative switch are not fully understood. The tumor microenvironment plays a key role in mediating cancer cell phenotype including regulation of the dormant state. In this review, we highlight cell-cell interactions in the tumor microenvironment mediating breast cancer dormancy at the primary and metastatic sites. Specifically, we describe how immune cells from the lymphoid lineage, tumor-associated myeloid lineage cells, and stromal cells of non-hematopoietic origin as well as tissue resident stromal cells impact dormancy vs. proliferation in breast cancer cells as well as the associated mechanisms. In addition, we highlight the importance of developing model systems and the associated considerations that will be critical in unraveling the mechanisms that promote primary and metastatic breast cancer dormancy mediated via cell-cell interactions.
Keywords: Breast cancer; Cell-cell interactions; Dormancy; Metastasis.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis: "An Ally that Changes Allegiances".Adv Exp Med Biol. 2025;1464:373-395. doi: 10.1007/978-3-031-70875-6_18. Adv Exp Med Biol. 2025. PMID: 39821034 Review.
-
Varying the RGD concentration on a hyaluronic acid hydrogel influences dormancy versus proliferation in brain metastatic breast cancer cells.J Biomed Mater Res A. 2024 May;112(5):710-720. doi: 10.1002/jbm.a.37651. Epub 2023 Nov 28. J Biomed Mater Res A. 2024. PMID: 38018303
-
Cellular dormancy in minimal residual disease following targeted therapy.Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9. Breast Cancer Res. 2021. PMID: 34088357 Free PMC article.
-
Regulation of Brain Metastatic Breast Cancer Cell Dormancy versus Proliferation on Hyaluronic Acid Hydrogels via Laminin and Laminin-Derived Peptides.ACS Appl Bio Mater. 2025 Apr 21;8(4):2824-2837. doi: 10.1021/acsabm.4c01386. Epub 2025 Mar 13. ACS Appl Bio Mater. 2025. PMID: 40083120
-
Mechanisms governing metastatic dormancy in breast cancer.Semin Cancer Biol. 2017 Jun;44:72-82. doi: 10.1016/j.semcancer.2017.03.006. Epub 2017 Mar 23. Semin Cancer Biol. 2017. PMID: 28344165 Review.
Cited by
-
Adjuvant Metronomic Chemotherapy After Surgery in pT1-T2 N0 M0 HER2-Positive and ER/PR-Positive Breast Cancer Plus Targeted Therapy, Anti-Hormonal Therapy, and Radiotherapy, with or Without Immunotherapy: A New Operational Proposal.Cancers (Basel). 2025 Apr 15;17(8):1323. doi: 10.3390/cancers17081323. Cancers (Basel). 2025. PMID: 40282499 Free PMC article.
-
Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges.Pharmaceuticals (Basel). 2025 Jun 26;18(7):961. doi: 10.3390/ph18070961. Pharmaceuticals (Basel). 2025. PMID: 40732251 Free PMC article. Review.
References
-
- Cancer Facts & Fig. (2023). American Cancer Society.
-
- American Cancer Society. (2023). Cancer statistics center. https://cancerstatisticscenter.cancer.org/?_gl=1*s0nztd*_ga*OTkwNTA1OTkz... . Accessed 20 Dec 2023.
-
- SEER*Explorer. (2024). An interactive website for SEER cancer statistics. https://seer.cancer.gov/statistics-network/explorer/ . Accessed 22 Jul 2024.
-
- Lim, A. R., & Ghajar, C. M. (2022). Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse. Seminars in Cancer Biology , 78, 104–123. https://doi.org/10.1016/j.semcancer.2021.05.007 - DOI - PubMed
-
- Elkholi, I. E., Lalonde, A., Park, M., & Côté, J. F. (2022). Breast Cancer metastatic dormancy and relapse: An Enigma of Microenvironment(s). Cancer Research, 82(24), 4497–4510. https://doi.org/10.1158/0008-5472.Can-22-1902 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical